Skip to main content
Erschienen in: Cancer Causes & Control 10/2011

01.10.2011 | Original paper

Inverse association between eczema and meningioma: a meta-analysis

verfasst von: Mei Wang, Chao Chen, Jintao Qu, Tao Xu, Yicheng Lu, Juxiang Chen, Shenhong Wu

Erschienen in: Cancer Causes & Control | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

The pathogenesis of primary brain tumors may be related to immune response. Prior studies have shown a strong association between allergy and glioma; however, so far no significant association has been established between allergy and meningioma. Here, we conducted a meta-analysis of published studies to investigate the association of meningioma with the overall and specific allergic conditions.

Methods

PubMed, EMBASE database, and Cochrane Library were searched for pertinent citations published between January 1979 and October 2009. We used the following searching strategy (brain tumor [Text Word] OR meningioma [Text Word]) AND (allergy [Text Word] OR atopy [Text Word] OR asthma [Text Word] OR eczema [Text Word] OR hay fever [Text Word]) to search for relevant studies. Random effect model was used to estimate the association between allergic conditions and meningioma.

Result

A total of 7 studies (5 case–control studies and 2 cohort studies) were included in the analysis, involving 54,391 participants, of whom 2,656 had meningioma. When compared to non-allergic conditions, the pooled odds ratio (OR) with any allergic conditions for meningioma was 0.91 (95% CI: 0.79–1.04, p = 0.163), suggesting that there is no significant association between meningioma and allergic conditions. Interestingly, further analysis showed that eczema had significantly inverse association with meningioma (OR, 0.75; 95% CI: 0.65–0.87, p < 0.05). On the other hand, no significant association was found for asthma (OR, 0.88; 95% CI: 0.75–1.04, p = 0.126) and hay fever (OR, 0.90; 95% CI: 0.79–1.03, p = 0.137).

Conclusion

In conclusion, there was a significantly negative association between eczema and meningioma, suggesting that eczema may reduce the risk of meningioma. Although it was not statistically significant association between meningioma and other specific allergic conditions such as asthma and hay fever, further studies with large sample size may be needed to determine its relationship.
Literatur
1.
Zurück zum Zitat Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197–205PubMedCrossRef Bondy M, Ligon BL (1996) Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197–205PubMedCrossRef
2.
Zurück zum Zitat Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD (1993) Epidemiology of intracranial meningioma. Cancer 72:639–648PubMedCrossRef Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD (1993) Epidemiology of intracranial meningioma. Cancer 72:639–648PubMedCrossRef
3.
Zurück zum Zitat Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828PubMedCrossRef Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, Niessen WJ et al (2007) Incidental findings on brain MRI in the general population. N Engl J Med 357:1821–1828PubMedCrossRef
4.
Zurück zum Zitat Rausing A, Ybo W, Stenflo J (1970) Intracranial meningioma—a population study of ten years. Acta Neurol Scand 46:102–110PubMedCrossRef Rausing A, Ybo W, Stenflo J (1970) Intracranial meningioma—a population study of ten years. Acta Neurol Scand 46:102–110PubMedCrossRef
5.
Zurück zum Zitat Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA et al (2007) Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 16:1655–1661PubMedCrossRef Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA et al (2007) Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 16:1655–1661PubMedCrossRef
6.
Zurück zum Zitat Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P et al (2008) Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 100:270–276PubMedCrossRef Bethke L, Murray A, Webb E, Schoemaker M, Muir K, McKinney P et al (2008) Comprehensive analysis of DNA repair gene variants and risk of meningioma. J Natl Cancer Inst 100:270–276PubMedCrossRef
7.
Zurück zum Zitat Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B et al (2005) Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14:969–976PubMedCrossRef Sadetzki S, Flint-Richter P, Starinsky S, Novikov I, Lerman Y, Goldman B et al (2005) Genotyping of patients with sporadic and radiation-associated meningiomas. Cancer Epidemiol Biomarkers Prev 14:969–976PubMedCrossRef
8.
Zurück zum Zitat Wrensch M, Bondy ML, Wiencke J, Yost M (1993) Environmental risk factors for primary malignant brain tumors: a review. J Neurooncol 17:47–64PubMedCrossRef Wrensch M, Bondy ML, Wiencke J, Yost M (1993) Environmental risk factors for primary malignant brain tumors: a review. J Neurooncol 17:47–64PubMedCrossRef
9.
Zurück zum Zitat Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299PubMed Wrensch M, Minn Y, Chew T, Bondy M, Berger MS (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299PubMed
10.
Zurück zum Zitat Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J et al (2009) History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol 24:433–440PubMedCrossRef Berg-Beckhoff G, Schuz J, Blettner M, Munster E, Schlaefer K, Wahrendorf J et al (2009) History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol 24:433–440PubMedCrossRef
11.
Zurück zum Zitat Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC et al (2007) Allergic conditions and brain tumor risk. Am J Epidemiol 166:941–950PubMedCrossRef Wigertz A, Lonn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC et al (2007) Allergic conditions and brain tumor risk. Am J Epidemiol 166:941–950PubMedCrossRef
12.
Zurück zum Zitat Schoemaker MJ, Swerdlow AJ, Hepworth SJ, van Tongeren M, Muir KR, McKinney PA (2007) History of allergic disease and risk of meningioma. Am J Epidemiol 165:477–485PubMedCrossRef Schoemaker MJ, Swerdlow AJ, Hepworth SJ, van Tongeren M, Muir KR, McKinney PA (2007) History of allergic disease and risk of meningioma. Am J Epidemiol 165:477–485PubMedCrossRef
13.
Zurück zum Zitat Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC et al (2003) Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 106:423–428PubMedCrossRef Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Lonn S, Soderberg KC et al (2003) Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer 106:423–428PubMedCrossRef
14.
Zurück zum Zitat Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM et al (2002) History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99:252–259PubMedCrossRef Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM et al (2002) History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 99:252–259PubMedCrossRef
15.
Zurück zum Zitat Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A et al (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155–160PubMedCrossRef Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A et al (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155–160PubMedCrossRef
16.
Zurück zum Zitat Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314PubMedCrossRef Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307–314PubMedCrossRef
17.
Zurück zum Zitat Ryan P, Lee MW, North B, McMichael AJ (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51:20–27PubMedCrossRef Ryan P, Lee MW, North B, McMichael AJ (1992) Risk factors for tumors of the brain and meninges: results from the Adelaide Adult Brain Tumor Study. Int J Cancer 51:20–27PubMedCrossRef
18.
Zurück zum Zitat Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99:1544–1550PubMedCrossRef Linos E, Raine T, Alonso A, Michaud D (2007) Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst 99:1544–1550PubMedCrossRef
19.
Zurück zum Zitat Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y et al (2010) Allergy and risk of glioma: a meta-analysis. Eur J Neurol 18:387–395PubMedCrossRef Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y et al (2010) Allergy and risk of glioma: a meta-analysis. Eur J Neurol 18:387–395PubMedCrossRef
21.
Zurück zum Zitat Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H et al (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65:6459–6465PubMedCrossRef Schwartzbaum J, Ahlbom A, Malmer B, Lonn S, Brookes AJ, Doss H et al (2005) Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res 65:6459–6465PubMedCrossRef
22.
Zurück zum Zitat Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG et al (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71:203–207PubMedCrossRef Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG et al (1997) Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 71:203–207PubMedCrossRef
23.
Zurück zum Zitat Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M et al (2010) Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev 19:1356–1361PubMedCrossRef Rajaraman P, Brenner AV, Neta G, Pfeiffer R, Wang SS, Yeager M et al (2010) Risk of meningioma and common variation in genes related to innate immunity. Cancer Epidemiol Biomarkers Prev 19:1356–1361PubMedCrossRef
24.
Zurück zum Zitat Chang M, Lee AJ, Fitzpatrick L, Zhang M, Sun SC (2009) NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation. J Immunol 182:3131–3138PubMedCrossRef Chang M, Lee AJ, Fitzpatrick L, Zhang M, Sun SC (2009) NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation. J Immunol 182:3131–3138PubMedCrossRef
25.
Zurück zum Zitat Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N et al (2008) Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 4:e1000166PubMedCrossRef Weidinger S, Gieger C, Rodriguez E, Baurecht H, Mempel M, Klopp N et al (2008) Genome-wide scan on total serum IgE levels identifies FCER1A as novel susceptibility locus. PLoS Genet 4:e1000166PubMedCrossRef
26.
Zurück zum Zitat Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM et al (2009) Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev 18:1651–1658PubMedCrossRef Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM et al (2009) Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev 18:1651–1658PubMedCrossRef
27.
Zurück zum Zitat Ellyard JI, Simson L, Parish CR (2007) Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 70:1–11PubMedCrossRef Ellyard JI, Simson L, Parish CR (2007) Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 70:1–11PubMedCrossRef
28.
Zurück zum Zitat Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J (1995) Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105:407–410PubMedCrossRef Grewe M, Walther S, Gyufko K, Czech W, Schopf E, Krutmann J (1995) Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105:407–410PubMedCrossRef
29.
Zurück zum Zitat Taha RA, Leung DY, Ghaffar O, Boguniewicz M, Hamid Q (1998) In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 102:245–250PubMedCrossRef Taha RA, Leung DY, Ghaffar O, Boguniewicz M, Hamid Q (1998) In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 102:245–250PubMedCrossRef
Metadaten
Titel
Inverse association between eczema and meningioma: a meta-analysis
verfasst von
Mei Wang
Chao Chen
Jintao Qu
Tao Xu
Yicheng Lu
Juxiang Chen
Shenhong Wu
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2011
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9808-6

Weitere Artikel der Ausgabe 10/2011

Cancer Causes & Control 10/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.